Kiora Pharmaceuticals
(NASDAQ) KPRX
Kiora Pharmaceuticals Financials at a Glance
Market Cap
$7.61M
Revenue (TTM)
$0.00
Net Income (TTM)
$8.54M
EPS (TTM)
$-2.46
P/E Ratio
-0.84
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$2.06
Volume
56,749
Open
$2.04
Price
$2.06
Volume
56,749
Open
$2.04
Previous Close
$2.03
Daily Range
$1.96 - $2.05
52-Week Range
$1.76 - $4.18
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$2.06
Volume
56,749
Open
$2.04
Previous Close
$2.03
Daily Range
$1.96 - $2.05
52-Week Range
$1.76 - $4.18
KPRX News
KPRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kiora Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
12
CEO
Brian Matthew Strem, PhD
Website
www.kiorapharma.comHeadquarters
Encinitas, UT 84105, US
KPRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-33%
Return on Capital
-30%
Return on Assets
-29%
Earnings Yield
-1.19%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.61M
Shares Outstanding
3.68M
Volume
56.75K
Short Interest
0.00%
Avg. Volume
46.06K
Financials (TTM)
Gross Profit
$16.00M
Operating Income
$4.51M
EBITDA
$5.70M
Operating Cash Flow
$8.56M
Capital Expenditure
$6.26K
Free Cash Flow
$8.55M
Cash & ST Invst.
$26.79M
Total Debt
$57.17K
Kiora Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$38.23K
N/A
Gross Margin
0.00%
N/A
Market Cap
$7.61M
N/A
Market Cap/Employee
$634.44K
N/A
Employees
12
N/A
Net Income
$26.81K
+100.8%
EBITDA
$2.50M
+7.1%
Quarterly Fundamentals
Net Cash
$18.97M
-34.5%
Accounts Receivable
$1.21M
-32.0%
Inventory
$0.00
N/A
Long Term Debt
$248.24K
+533.4%
Short Term Debt
$155.93K
+366.2%
Return on Assets
-28.60%
N/A
Return on Invested Capital
-29.64%
N/A
Free Cash Flow
$1.27M
-238.4%
Operating Cash Flow
$1.27M
-238.4%